FDA
approval
· 2025-12-17
FDA Approved: TRAVOPROST OPHTHALMIC SOLUTION — Original Application (Alembic Pharmaceuticals Inc.)
Summary
FDA approved Travoprost Ophthalmic Solution under an Original ANDA filed by Alembic Pharmaceuticals, indicated to reduce intraocular pressure in open-angle glau…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for TRAVOPROST OPHTHALMIC SOLUTION (TRAVOPROST OPHTHALMIC)